News & Events

• April 1, 2015
  

  Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects

  Pai M, Schito M. Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects. The Journal of Infectious Diseases. 2015 Apr 1;211 Suppl 2:S21–8.

• April 1, 2015
  

  Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers

  Denkinger CM, Dolinger D, Schito M, Wells W, Cobelens F, Pai M, Zignol M, Cirillo DM, Alland D, Casenghi M, Gallarda J, Boehme CC, Perkins MD. Target Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers. The Journal of Infectious Diseases. 2015 Apr 1;211 Suppl 2:S39–49.

• March 1, 2015
  

  Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease

  Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D, Salloway S, Trojanowski JQ, Bountra C, Krams M, Luthman J, Potkin S, Gribkoff V, Temple R, Wang Y, Carrillo MC, Stephenson D, Snyder H, Liu E, Ware T, McKew J, Fields FO, Bain LJ, Bens C. Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease. Expert Review of Neurotherapeutics. 2015 Mar;15(3):327–33.

• January 1, 2015
  

  Charting A Path Toward Combination Therapy For Alzheimer’s Disease

  Stephenson D, Perry D, Bens C, Bain LJ, Berry D, Krams M, Sperling R, Dilts D, Luthman J, Hanna D, McKew J, Temple R, Fields FO, Salloway S, Katz R. Charting A Path Toward Combination Therapy For Alzheimer’s Disease. Expert Review of Neurotherapeutics. 2015 Jan;15(1):107–13.

• December 1, 2014
  

  Modeling And Simulation For Medical Product Development And Evaluation: Highlights From The FDA-C-Path-ISOP 2013 Workshop

  Romero K, Sinha V, Allerheiligen S, Danhof M, Pinheiro J, Kruhlak N, Wang Y, Wang S-J, Sauer J-M, Marier JF, Corrigan B, Rogers J, Lambers Heerspink HJ, Gumbo T, Vis P, Watkins P, Morrison T, Gillespie W, Gordon MF, Stephenson D, Hanna D, Pfister M, Lalonde R, Colatsky T. Modeling And Simulation For Medical Product Development And Evaluation: Highlights From The FDA-C-Path-ISOP 2013 Workshop. Journal of Pharmacokinetics and Pharmacodynamics. 2014 Dec;41(6):545–52.